• Home >>
  • Pharmaceuticals and Healthcare >>
  • Optic Nerve Glioma Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Optic Nerve Glioma Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 178241 April, 2018 Region : Global Pages Reports Monitor

Optic Nerve Glioma Market


Market Synopsis:

Optic nerve glioma is a kind of brain tumor that grows on nerves and carries vision from eyes to brain. Optic nerve glioma is rarely found in the individuals over the age of 20, and is associated with genetic disorder neurofibromatosis type 1, or NF1. It is found in approximately one of five children with NF1. This type of tumor is commonly found in young children and can affect their vision. These tumors don’t grow as quickly as others and is considered to be low grade. 


The global optic nerve glioma market is driven by various factors such as increasing cases of the disease couple with technological advancements and novel methods for diagnosis have led to the growth of the market. This disease is associated with NF1 in approximately 10% of cases and represents an additional risk for systemic tumors. However, this type of tumor can be treated by surgery and radiation therapy. Surgery mainly includes high risk of brain damage and high cost. Moreover, radiation therapy leads to the damage to eyes and brain, high cost, and other side effects associated with its use such as vomiting, reduced immunity, hair loss etc.


According to NCBI, the prevalence of neurofibromatosis type 1 (NF1) is about 1/3,000. The prevalence is somewhat higher in young children than in adults, a difference that probably results at least in part from the early death of some NF1 patients.


Market segmentation:

Based on the segmentation, the market is bifurcated into type, diagnosis, treatment, end-user and region. The type segment is further divided into malignant optic nerve glioma and benign optic nerve glioma. On the basis of diagnosis, the market is segmented into neurological exam, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), biopsy and others. Moreover, the treatment segment is split into surgery, radiation therapy, chemotherapy and others. The end-users of the market include pharmacy hospitals & clinics, diagnostic centers and others.


Regional analysis:

According to the regional analysis, the market is divided into various geographic regions such as North America, Europe, APAC, and LAMEA. The demand of this market is growing in North America, owing to extensive use of medications and high expenditures associated with health care.


Key Players:

Based on the competitive analysis, the major players profiled in the market includes Emcure Pharmaceuticals ltd., Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Pfizer Inc., Taj Pharmaceuticals Limited, Novartis International AG, Teva Pharmaceutical Industries Ltd, GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation and others.


Optic Nerve Glioma Market Segmentation

By Type: 

• Malignant Optic Nerve Glioma

• Benign Optic Nerve Glioma


By Diagnosis:

• Neurological Exam

• Computed Tomography (CT)

• Magnetic Resonance Imaging (MRI)

• Biopsy

• Others


By Treatment: 

• Surgery

• Radiation Therapy

• Chemotherapy

• Others


By End-User: 

• Pharmacy Hospitals & Clinics

• Diagnostic Centers

• Others


Regions Covered:

• North America 

• Europe

• Asia-Pacific 

• LAMEA

Research Scope

 

The study for Global Optic Nerve Glioma Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

 

1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 


4. Type Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Malignant Optic Nerve Glioma

4.2.2. Benign Optic Nerve Glioma

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Diagnosis Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Neurological Exam

5.2.2. Computed Tomography (CT)

5.2.3. Magnetic Resonance Imaging (MRI)

5.2.4. Biopsy

5.2.5. Others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Treatment Overview

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. Surgery

6.2.2. Radiation Therapy

6.2.3. Chemotherapy

6.2.4. Others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. End-User Overview

7.1. Introduction

7.2. Market Size & Forecast, 2015 to 2025

7.2.1. Pharmacy Hospitals & Clinics

7.2.2. Diagnostic Centers

7.2.3. Others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Regional Overview

8.1. Introduction

8.2. Market Size & Forecast, 2015 to 2025

8.2.1. North America

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.1.3. Mexico 

8.2.2. Europe

8.2.2.1. UK

8.2.2.2. Germany

8.2.2.3. France

8.2.2.4. Italy 

8.2.2.5. Spain

8.2.2.6. Rest of Europe

8.2.3. Asia-Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Rest of Asia-Pacific

8.2.4. LAMEA

8.2.4.1. Brazil

8.2.4.2. UAE

8.2.4.3. South Africa

8.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


9. Manufacturer/ Vendor Profile

9.1. The following attributes will be considered while profiling key manufacturers in this industry: 

9.1.1. Company Overview

9.1.2. Financial Synopsis

9.1.3. Recent Developments

9.1.4. R&D Investments (if any)

9.1.5. Strategy Overview (Analyst Perspective)

9.1.6. Product Portfolio

9.2. Companies Profiled

9.2.1. Emcure Pharmaceuticals ltd.

9.2.2. Sigma-Aldrich Co.

9.2.3. Thermo Fisher Scientific Inc.

9.2.4. Pfizer Inc.

9.2.5. Taj Pharmaceuticals Limited

9.2.6. Novartis International AG

9.2.7. Teva Pharmaceutical Industries Ltd

9.2.8. GE Healthcare

9.2.9. Siemens Healthcare

9.2.10. Philips Healthcare

9.2.11. Shimadzu Corporation

9.2.12. Toshiba Medical Systems Corporation

 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]